qualitative and quantitative analysis of pharmaceutical materials. Prototype instruments and
algorithms for sampling strategies and data analyses were developed to achieve pharmaceutical
materials analysis with low limits of detection and short measurement times.
Manufacturing an amorphous solid dispersion (ASD), in which an amorphous active
pharmaceutical ingredient (API) within polymer matrix, is an effective approach to improve the
solubility and bioavailability of a drug. However, since ASDs are generally metastable materials,
they can often transform to produce crystalline API with higher thermodynamic stability.
Analytical methods with low limits of detection for crystalline APIs were used to assess the
stability of ASDs. With high selectivity to noncentrosymmetric crystals, SHG microscopy was
demonstrated as an analytical tool, which exhibited a limit of detection of 10 ppm for ritonavir
Form II crystals. SHG microscopy was employed for accelerated stability testing of ASDs, which
provided a four-decade dynamic range of crystallinity for kinetic modeling. An established model
was validated by investigating nucleation and crystal growth based on SHG images. To achieve in
situ accelerated stability testing, controlled environment for in situ stability testing (CEiST) was
designed and built to provide elevated temperature and humidity, which is compatible with a
commercial SHG microscope based on our research prototype. The combination of CEiST and
SHG microscopy enabled assessment of individual crystal growth rates by single-particle tracking
and nucleation rates for individual fields of view with low Poisson noise. In addition, SHG
microscopy coupled with CEiST enabled the study of heterogeneity of crystallization kinetics
within pharmaceutical materials.
Polymorphism of APIs plays an important role in drug formulation development. Different
polymorphs of identical APIs may exhibit different physiochemical properties, e.g., solubility,
stability, and bioavailability, due to their crystal structures. Moreover, polymorph transitions may take place during the manufacturing process and storage. Therefore, analytical methods with high
speed for polymorph characterization, which can provide real-time feedback for the polymorphic
transition, have broad applications in pharmaceutical materials characterization. Raman
spectroscopy is able to determine the API polymorphism, but is hampered by the long
measurement times. In this study, two analytical methods with high speed were developed to
characterize API polymorphs. One is SHG microscopy-guided Raman spectroscopy, which
achieved the speed of 10 ms/particle for clopidogrel bisulfate. Initial classification of two different
polymorphs was based on SHG images, followed acquisition of Raman spectroscopy at the
selected positions to determine the API crystal form. Another approach is implementing of
dynamic sampling into confocal Raman microscopy to accelerate Raman image acquisition for 6-
folds. Instead of raster scanning, dynamic sampling algorithm enabled acquiring Raman spectra at
the most informative locations. The reconstructed Raman image of pharmaceutical materials has
<0.5% loss of image quality with 15.8% sampling rate. Less